Abstract:AIMTo evaluate the performance of a novel non-invasive controlled attenuation parameter (CAP) to assess liver steatosis.METHODSThis was a multi-center prospective cohort study. Consecutive patients (aged ≥ 18 years) who had undergone percutaneous liver biopsy and CAP measurement were recruited from three Chinese liver centers. Steatosis was categorized as S0: < 5%; S1: 5%-33%; S2: 34%-66%; or S3: ≥ 67%, according to the nonalcoholic fatty liver disease (NAFLD) activity score. The FibroScan(®) 502 equipped with the M probe (Echosens, Paris, France) was used to capture both CAP and liver stiffness measurement values simultaneously. Receiver operating characteristic curves were plotted, and the areas under the curves were calculated to determine the diagnostic efficacy. The accuracy of the CAP values at the optimal thresholds was defined by maximizing the sum of sensitivity and specificity (maximum Youden index).RESULTSA total of 152 patients were recruited, including 52 (34.2%) patients with NAFLD and 100 (65.8%) with chronic hepatitis B (CHB) virus infection. After adjustment, the steatosis grade (OR = 37.12; 95%CI: 21.63-52.60, P < 0.001) and body mass index (BMI, OR = 6.20; 95%CI: 2.92-9.48, P < 0.001) were found independently associated with CAP by multivariate linear regression analysis. CAP was not influenced by inflammation, fibrosis or aetiology. The median CAP values and interquartile ranges among patients with S0, S1, S2 and S3 steatosis were 211 (181-240) dB/m, 270 (253-305) dB/m, 330 (302-360) dB/m, and 346 (313-363) dB/m, respectively. The cut-offs for the CAP values in all patients with steatosis ≥ 5%, ≥ 34% and ≥ 67% were 253 dB/m, 285 dB/m and 310 dB/m, respectively. The areas under the curves were 0.92, 0.92 and 0.88 for steatosis ≥ 5%, ≥ 34% and ≥ 67%, respectively. No significant differences were found in the CAP values between the NAFLD group and the CHB group in each steatosis grade.CONCLUSIONCAP appears to be a promising tool for the non-invasive detection and quantification of hepatic steatosis, but is limited by BMI.

Clinical research of fibroscan ‒ TE-CAP at noninvasive diagnosis of hepatic steatosis in children

Controlled Attenuation Parameter by VCTE for Steatosis Assessment in Health Check Public with Reference to MRI-PDFF.

Controlled attenuation parameter for steatosis assessment in health checkup groups

Transient Elastography in Alcoholic Liver Disease and Nonalcoholic Fatty Liver Disease: A Systemic Review and Meta-Analysis

A meta-analysis on the diagnostic performance of magnetic resonance imaging and transient elastography in nonalcoholic fatty liver disease

[Diagnostic Value of Ultrasonographic Examination for Hepatic Steatosis in Obese Children].

Liver Stiffness and Hepatic Steatosis Measurement of Preschool Children in Shanghai by Using Transient Elasto-Graphy

Controlled attenuation parameter (CAP): the clinical value based on MRI-PDFF in children with obesity

Feasibility study and reference values of FibroScan 502 with M probe in healthy preschool children aged 5 years

Controlled attenuation parameter by vibration-controlled transient elastography for steatosis assessment in members of the public undergoing regular health checkups with reference to magnetic resonance imaging-based proton density fat fraction

Controlled Attenuation Parameter for Non-Invasive Assessment of Hepatic Steatosis in Chinese Patients

Predicting Hepatic Steatosis and Liver Fat Content in Obese Children Based on Biochemical Parameters and Anthropometry

Intrahepatic Fat Content and Markers of Hepatic Fibrosis in Obese Children

Performance of Imaging Techniques in Non-invasive Diagnosis of Non-alcoholic Fatty Liver Disease in Children: A Systematic Review and Meta-Analysis

Influential factors and clinical value of controlled attenuation parameters in the evaluation of hepatic steatosis using FibroScan?

[A Multi-Center Clinical Study of a Novel Controlled Attenuation Parameter for Assessment of Fatty Liver].

Development and Validation of a Novel Non-Invasive Test for Diagnosing Nonalcoholic Fatty Liver Disease in Chinese Children

Diagnostic value of FibroTouch in identifying hepatic steatosis in NAFLD with MRI-PDFF as the reference standard

A new visual quantitative assessment of ultrasound attenuation parameters for the mild liver steatosis

A novel score based on CAP accurately predicts hepatic steatosis in individuals with nonalcoholic fatty liver disease: a derivation and independent validation study

Diagnostic Accuracy of Controlled Attenuation Parameter (CAP) As a Non-Invasive Test for Steatosis in Suspected Non-Alcoholic Fatty Liver Disease: a Systematic Review and Meta-Analysis